top of page

When the Buyer Already Has a Solution: What's Your Next Move?

Writer: Demi Radeva
Demi Radeva
3 minutes ago
8 min read

Why understanding a buyer’s existing vendor ecosystem can help HealthTech companies identify gaps, strengthen their competitive positioning, and advance payer conversations.


For HealthTech companies selling to health plans, employers, and other enterprise healthcare buyers, one of the most common objections can also be one of the most valuable sources of commercial insight.


“We already have a solution for that.”


At first, this response may suggest that the opportunity is closed. The buyer has an established vendor relationship, an existing program, or internal capabilities addressing the same problem.


But the presence of an existing solution does not necessarily mean the buyer’s needs are fully met.


Healthcare organizations often manage multiple vendors addressing overlapping clinical, operational, and member engagement priorities. Some programs work well independently but create challenges when integrated into broader workflows. Others may deliver measurable results without addressing every aspect of the buyer’s needs.


For HealthTech founders, understanding these existing relationships is an important part of evaluating payer-market fit.


The commercial opportunity may involve replacing an underperforming vendor, complementing an established program, or partnering with another organization to address a gap neither solution can solve independently.


The challenge is determining whether that opportunity exists, who owns it, and what would justify a change.



Why the Existing Vendor Ecosystem Matters 


Health plans and employers rarely evaluate new technology solutions in isolation.

Purchasing decisions take place within an established environment of vendor contracts, internal programs, technology infrastructure, budgets, and organizational priorities.


Two recent industry perspectives highlight why understanding this environment is becoming increasingly important.


Mercer's Choosing the Right Benefits Partner in a Complex Vendor Ecosystem examines the importance of evaluating how different benefits programs work together across the member journey.


A benefits portfolio may include separate vendors supporting behavioral health, chronic disease management, care navigation, and other services. While each program may address a legitimate need, overlapping capabilities and unclear responsibilities can make it difficult to understand how the broader ecosystem performs.


Gartner's The AI Vendor Race offers a complementary perspective on competitive positioning. As technology markets become increasingly crowded, companies need to understand their place within the broader ecosystem and identify where they can establish a defensible advantage.


Together, these perspectives highlight an important consideration for HealthTech commercialization.


The presence of an established solution can indicate both competitive pressure and an existing organizational commitment to addressing a particular problem.


A health plan investing in care navigation, for example, has already demonstrated that helping members access appropriate services is a priority.


That does not automatically create demand for another navigation solution. However, it provides a starting point for understanding how the organization approaches the problem, what outcomes it expects, and whether its current capabilities leave meaningful gaps.


For founders, the objective is to move beyond identifying a clinical or operational need and determine how their solution fits into the buyer's existing strategy.



Understanding the Economics of Vendor Overlap


Adding another healthcare technology vendor creates costs beyond the contract price.

Health plans must consider implementation, data integration, staff training, ongoing vendor management, and the operational resources required to support a new program.

Even when a solution offers meaningful clinical benefits, these additional requirements can make adoption difficult to justify.


Consider a health plan that already contracts with a vendor providing chronic disease management services.


A new HealthTech company may offer stronger patient engagement capabilities, more personalized interventions, or improved clinical monitoring.


However, the buyer must evaluate several questions before considering another investment:


  • Existing capabilities: Which services are already available through the current vendor, and where are the limitations?

  • Incremental value: What additional outcomes would the new solution deliver beyond the existing program?

  • Operational impact: Would implementation reduce administrative burden or introduce additional complexity?

  • Financial implications: Would the expected benefits justify the incremental cost of another vendor?

  • Contractual considerations: Could the proposed solution operate alongside the current contract, or would changes to existing arrangements be required?


These questions help distinguish a meaningful commercial opportunity from a solution that simply duplicates existing capabilities or one that wouldn’t be worth the investment.

For example, a new chronic disease management platform may demonstrate better engagement rates than an existing vendor.


But if the health plan already has a multiyear agreement covering the same population, higher engagement alone may not justify introducing another platform or fighting to switch platforms.


The company would need to demonstrate how its capabilities address an unmet need, improve measurable outcomes, or reduce costs enough to support the investment.


In some cases, the strongest opportunity may be to integrate a specific capability into the existing program rather than compete for the entire contract.


Understanding these economics can help founders develop a more robust commercialization strategy before entering procurement discussions.



Commercial Opportunities Within an Existing Ecosystem


When a buyer already has a solution in place, HealthTech companies generally have a few  potential paths to explore.

Each requires a different value proposition, commercial approach, and understanding of the buyer's decision-making process.


Alternative paths to consider

The right approach depends on what the buyer wants to improve and how its existing solution is delivered. Use discovery to explore these alternatives before deciding what to propose.


  1. Complement the existing solution

The buyer already has a functioning program, but a specific part of it falls short. Your opportunity is to improve that program while keeping its core capabilities in place. That can mean supporting an internal team as well as adding a capability alongside an existing vendor.


For example, an existing care management team may coordinate appointments but struggle to reach members who need outreach in additional languages. A specialized outreach service could support that team. The pitch should specify which members it would reach, how handoffs would work, and what additional results it would deliver without duplicating existing services.


Ask: “Which part of the current process needs more support?” Then propose a workflow review with the program owner. Be clear about what the buyer would purchase from you, what its current vendor or team would continue to do, and how you would measure the improvement.


  1. Partner with an existing vendor

An existing vendor may be able to deliver your capability as part of its offering. For example, a benefits platform could add your specialized intervention instead of the buyer purchasing it separately. You can explore this from either side of the relationship.


Start with the buyer. If the buyer identifies a limitation in its current vendor’s offering, ask: “Would you be willing to introduce us to your vendor and initiate a discussion about adding this capability?” A buyer can bring a specific customer need to the vendor and help convene a joint conversation.


Start with the vendor. Approach its partnerships or product team with a specific use case and ask: “Could we help you deliver this capability under your own brand?” The vendor could integrate your technology, subcontract a service, or white-label your solution while retaining the customer relationship. Lead with how you help it deliver, expand, or retain business. Requesting customer introductions too early can make you look like a competitor for that relationship.


Next, work with the vendor to define the delivery model, pricing, branding, customer ownership, and support responsibilities. Agree on whether you would have any direct customer contact. A vendor-led arrangement may operate behind the scenes without a customer introduction or separate purchase; establish any disclosure or approval requirements under the existing contract before delivery. A joint buyer conversation is one possible route, not a prerequisite for partnership.


  1. Replace the existing solution

Replacement usually demands the strongest case for change. Even a dissatisfied buyer may hesitate when switching requires contract changes, data migration, retraining, or disruption to member services. The existing solution could be an external vendor or an internal operation.


Ask: “What would need to improve enough to make switching worthwhile, and when could you consider a change?” If there is an opening, propose a comparison against the buyer’s current performance and a transition discussion with the program owner. Address renewal timing, migration, and implementation responsibilities. “Our technology is better” is rarely enough on its own.



From Competitive Positioning to a Defensible Value Proposition


Understanding the existing ecosystem is only useful if that knowledge informs how a company positions its solution.


A common challenge for HealthTech founders is relying on broad differentiation claims.

Statements about better technology, stronger engagement, or more personalized care may describe genuine product advantages, but they do not necessarily explain why a buyer should make a change.


A stronger value proposition connects those advantages to a specific limitation in the buyer's current approach.


Consider two companies approaching a health plan that already offers digital musculoskeletal care.


The first company presents its platform as a superior alternative, emphasizing advanced technology, stronger patient engagement, and improved clinical monitoring. Its pitch focuses on why the health plan should replace its existing solution, without demonstrating what the current program is failing to deliver.


The second company takes a different approach. Rather than assuming the health plan needs a replacement, it investigates the existing program and identifies a specific gap: members are completing their clinical appointments but struggling to follow through with rehabilitation activities at home.


Instead of proposing another comprehensive MSK platform, the second company positions its technology as a complementary capability that addresses this gap. It demonstrates how its solution could support at-home adherence, give clinicians visibility into recovery between appointments, and improve outcomes for a defined member population.


It proposes evaluating that capability within a defined population and measuring outcomes relevant to the health plan.


The second approach may be better positioned to generate a productive conversation because it connects the solution to a specific operational need.


That does not guarantee a contract. The buyer must still determine whether the proposed benefits justify the costs and whether the solution can be implemented effectively.

But it provides a more concrete basis for evaluating commercial fit.


For HealthTech companies, defensible differentiation requires understanding not only what their product does well, but also why that capability matters within the buyer's current environment.



Building a Stronger Path to Payer Adoption


Existing vendor relationships are a fundamental part of healthcare commercialization.

Health plans, employers, providers must balance innovation with financial discipline, operational capacity, and the performance of programs already in place.


For HealthTech companies, this means that identifying an unmet clinical need is only the beginning.


A strong go-to-market strategy must also establish how the solution fits into the buyer's existing ecosystem, what incremental value it delivers, who benefits financially or operationally, and what would justify a purchasing decision.


Sometimes the opportunity will involve replacing an existing vendor. Other times, it will involve complementing an existing program or developing a strategic partnership.


And in some cases, the most valuable outcome of discovery will be recognizing that the buyer does not currently have a compelling reason to change.


Understanding those distinctions helps founders allocate commercial resources more effectively, refine their positioning, and pursue opportunities with a more credible path to adoption.


The next time a buyer says, “We already have that,” the conversation does not necessarily have to end.


It may be the starting point for understanding where your solution could create value.



Make the fit clear in your next conversation


Ask: “What is working well with your current approach, and where does it fall short?” Then establish whether the buyer wants support for the current solution, sees potential for a vendor partnership, or has a reason to consider replacement.


Then connect your proposal to that specific opening. Explain what changes for the buyer, what stays in place, and what implementation would require. The strongest opportunity is one the buyer recognizes, can fund, and has a reason to pursue now.



Find Your Next Commercial Opportunity with Akros Advisory


Understanding where your solution fits within a payer's existing ecosystem is an important step toward building a stronger commercialization strategy.


Akros Advisory helps HealthTech companies evaluate their market opportunities, understand healthcare buyer priorities, and identify practical paths to enterprise adoption.


Through our BD-in-a-Box offering, we help founders map the competitive and partner ecosystem, identify potential buyers and commercial openings, refine their value propositions, and prepare for the conversations that move opportunities forward.


Already navigating an established vendor landscape or preparing for an important buyer conversation?


Connect with Akros Advisory to explore how your solution fits into the market and identify your next commercial step.


Related Reading

Comments


The Akros Advantage: GTM Insights Delivered Straight to Your Inbox

Don’t miss what’s next in HealthTech. Subscribe to the Akros Advantage for fresh payer insights, upcoming events, practical tools to help your solution scale, and more from the Akros team.

bottom of page